Title: Global Atopic Dermatitis Market Report: 2016 Edition - New Report by Koncept Analytics
1Global Atopic Dermatitis Market Report
----------------------------------------- 2016
View Report Details
2View Report Details
- Executive Summary
- The atopic dermatitis market is set to form a
prominent segment of the pharmaceutical industry.
Atopic dermatitis (AD) is a chronic, inflammatory
skin disease of unknown origin that usually
starts in early infancy, but also affects a
substantial number of adults. Atopic dermatitis
is a long lasting skin disease that affects a
large percentage of the world's population and is
a special type of hypersensitivity that is
associated with asthma, inhalant allergies (hay
fever), and a chronic dermatitis. The symptoms of
atopic dermatitis are itching, red to brownish
grey patches and small raised bumps. - The main cause of atopic dermatitis is unknown
but it is assumed to be caused due to genetics,
dry skin and environmental conditions. Multiple
factors can trigger or worsen atopic dermatitis,
including low humidity, seasonal allergies,
exposure to harsh soaps and detergents, and cold
weather. There has been no specified biologic
till now for atopic dermatitis. But recent
efforts by many companies have shown positive
results and the first biologic named as dupilumab
may get launched in 2017. After that many other
products are still in pipeline. - The key factors which are anticipated to drive
atopic dermatitis market include increase in
global population, improvement in the global
health care expenditure, accelerated economic
growth, pollution and climatic factors and role
of triggers. Some of the significant developments
of this industry include introduction of new
biologics, biomarker in atopic dermatitis and
opportunity for new entrants. However, the
challenge to be faced ahead is time to be taken
in drug adoption, high price and legal
regulations. - This report offers a comprehensive analysis of
the atopic dermatitis market. Furthermore, market
dynamics such as key trends and development and
challenges are analyzed in depth. On the
contention front, the global stent market is
reined by few major players namely Sanofi, Glaxo
Smithkline (GSK), AstraZeneca and Roche Holding.
The competitive landscape of the respective
market, along with the company profiles of the
leading players are also discussed in detail.
3Increase in global population, rising healthcare
expenditure, pollution climatic factors, and
role of triggers will drive the global atopic
dermatitis market.
- The global atopic dermatitis market is expected
to become active by 2017 with US.. million and
is estimated to reach US..... million by 2025. - As of 2015, there are .. million adults
affected with atopic dermatitis globally which is
expected to increase gradually and reach ..
million by 2025. - The number of adults diagnosed with atopic
dermatitis globally is estimated to increase from
. million in 2015 to .. million by 2025. - There are .. thousands of adult patients in the
US that are refractory to topical therapies and
this number is estimated to increase to .
thousands by 2025.
Global Atopic Dermatitis Treatment Forecast by
Value (2017E-2025E)
Global Adult Affected with Atopic Dermatitis by
Volume (2015-2025E)
Global Adult Diagnosed with Atopic Dermatitis by
Volume (2015-2025E)
4Introduction of new biologics and the use of
biomarkers in atopic dermatitis market are the
latest developments and trends.
Global Adult with Moderate to Severe Atopic
Dermatitis (2015-2025E)
- The total number of adults suffering from
moderate to severe atopic dermatitis is ..
thousands in 2015 and is estimated to increase to
thousands by 2025. - There are .. thousands of adult patients
globally that are refractory to topical therapies
and this number is estimated to increase to .
thousands by 2025. - The revenue for atopic dermatitis market is
estimated to increase from US..... million in
2017 to US.... million by 2025 in the US. - Over .. million adults in the European Union are
affected with atopic dermatitis as of 2015. The
number is expected to increase consistently to
US..... million by 2025.
Global Adult Refractory to Topical Therapies
(2011-2017 E)
The US Atopic Dermatitis Treatment Forecast by
Value (2017E-2025E)
5Time taken to adopt the drugs, high price and
legal regulations are the main challenges to the
atopic dermatitis market.
The US Adult Affected with Atopic Dermatitis
(2015-2025E)
- There are a total of . million adults affected
with atopic dermatitis in the US and the number
is expected to reach .. million by 2025. - It is estimated that .. thousand patients would
be treated in the US by 2017 and the number of
treated patients is projected to reach ..
thousand by 2025. - It is estimated that .. thousand patients would
be treated in the European Union by 2018 and the
number of treated patients is projected to reach
thousand by 2025. - The number of adults diagnosed with atopic
dermatitis in European Union is estimated to
increase from .. million in 2015 to . million
by 2025.
The US Treated Patients by Volume (2017E-2025E)
European Union Treated Patients by Volume
(2018E-2025E)
6Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Atopic Dermatitis Market . To know more about
this report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com